DRNEXT LTD
DRNEXT LTD operates a modular AI-powered digital health platform offering AI symptom triage, cancer risk detection, mental health support, and virtual GP consultations, targeting NHS organisations, private health insurers, and individual patients in the UK and Iran.
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What DRNEXT LTD does
DRNEXT LTD operates a modular AI-powered digital health platform that delivers AI symptom triage, virtual GP consultations, AI-driven cancer risk detection, and computational psychiatry-based mental health support. The company was founded in 2021 by Dr. Saeid Taheri as DrNext.ir in Iran, where the platform has recorded 70 million+ visits, served 12 million+ patients, and is used by 15,000+ physicians. The UK expansion under DrNext.co.uk launched in 2024 and is supported by DrNext Ltd. (UK private limited company) and DrNext Inc. (USA). Ownership is founder-dominant, with no disclosed institutional funding rounds and family investor involvement through Abdolkarim Taheri (Investor & Head of Finance); a wholly-owned subsidiary, PsychoNext, houses the mental health product line.
The platform's technology stack combines probabilistic reasoning engines, neural networks, Bayesian inference, reinforcement learning, and large language model-guided generative AI, with proprietary training data comprising 50 million+ patient records for the symptom checker and 1M+ labeled cancer cases for the risk detection model. Four core products — AI Symptom Checker, Virtual GP, AI Cancer Risk Detection, and the Mental Health Solution (PsychoNext) — are designed to interoperate with NHS referral workflows including 2WW cancer pathways and ICS structures, integrating EHR and electronic referral tools.
Revenue is generated via subscription/recurring licensing of AI modules to NHS organisations (ICSs, PCNs, GP practices) and private health insurers, alongside direct-to-patient services. The go-to-market is sales-led and consultative, with quote-based enterprise pricing and no publicly disclosed price tiers, ARR, or revenue figures. Marketing emphasis is on thought-leadership content addressing specific NHS care gaps (GP access waits, cancer referral delays, mental health service dissatisfaction). The company has not disclosed certifications, regulatory clearances, named enterprise customers, or completed funding rounds in the source material.
DRNEXT LTD firmographics
Firmographics- Name
- DRNEXT LTD
- Legal name
- DrNext Inc.
- Website
- https://drnext.co.uk
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- DRNEXT LTD operates a modular AI-powered digital health platform offering AI symptom triage, cancer risk detection, mental health support, and virtual GP consultations, targeting NHS organisations, private health insurers, and individual patients in the UK and Iran.
- Ownership category
- akta.pro rank
DRNEXT LTD industry classification
Industry- Product category
- Digital Health Platform
- NAICS
- Offices of Physicians, Mental Health Specialists (621112)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Integrated Virtual-First Primary + Urgent Hybrid Platforms (HLALAJAM)
- akta.pro secondary industries
- Primary Care & General Medicine Virtual Care (HLALAAAA), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Psychiatry & Medication Management Platforms (HLALAEAB), General Medical Virtual Primary Care (Payer-Branded) (HLALACAA), Care Navigation, Advocacy & Benefits Guidance Platforms (HLALADAJ)
Keywords
Where DRNEXT LTD is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
DRNEXT LTD business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- NHS/Healthcare System Licensing: Licensing of AI modules to NHS organisations (ICSs, PCNs, GP practices) for AI triage, early cancer detection, and mental health assessments. Supports Long Term Plan goals with digital-first care solutions.
- Private Health Insurer Licensing: Licensing AI modules to private health insurers to reduce claims, enhance early intervention, and provide high-value digital health tools to members.
- Direct-to-Patient Services: Patient-facing platform offering AI-powered symptom checking, virtual GP visits, and mental health tools for individuals seeking faster access to care, particularly those facing NHS delays.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
DRNEXT LTD product offering
Product offeringCore offering
DrNext provides an AI-powered digital health platform comprising four modular products: an AI Symptom Checker for intelligent triage trained on 50 million patient records; a Virtual GP platform offering same-day video consultations with integrated EHR and referral tools; an AI Cancer Risk Detection system using machine learning to predict high-risk patients without imaging; and a Mental Health Solution combining gamified computational psychiatry with LLM-guided intake. The platform is licensed to NHS organisations and private health insurers and is also accessible directly to individual patients.
Product overview
DrNext provides a scalable, modular digital health platform that combines four core AI-powered products: AI Symptom Checker for intelligent triage, Virtual GP for video consultations, AI Cancer Risk Detection for predictive cancer screening, and Mental Health Solution for computational psychiatry-based mental health support. The platform is designed to address NHS service gaps by enabling earlier detection, faster triage, and personalized digital care, with components that integrate into unified patient pathways from initial symptom assessment through specialist referral.
Differentiator
Problem solved
Functional benefit
Brands
- PsychoNext: Mental health solution featuring gamified computational psychiatry tasks and AI-guided intake using LLMs, led by Dr. Sharareh Abdallah Khani as Co-Founder and Head of Mental Health Solution.
Products and services
- AI Symptom Checker AI-powered digital triage tool trained on 50 million patient records that uses a probabilistic reasoning engine and neural networks to dynamically assess symptoms, estimate diagnosis likelihood via Bayesian inference, and direct patients to appropriate care pathways (self-care, pharmacy, virtual GP, or secondary care). Designed for NHS organisations, private health insurers, and individual patients.
- Virtual GP Secure, high-quality video consultation platform providing same-day or next-day GP appointments. Presents clinicians with pre-collected structured data, clinical summaries, flagged red-flag symptoms, and ranked potential diagnoses, with integrated EHR and electronic referral tools to reduce administrative burden. Targeted at NHS GP practices, private health insurers, and individual patients.
- AI Cancer Risk Detection Machine learning system trained on over one million categorised cancer patient records that predicts high-risk patients from self-reported symptoms and health data without requiring imaging. Includes algorithmic prioritisation, urgency scoring, automated referral pathways, and integration with NHS workflows such as 2WW and ICS pathways. Targeted at NHS organisations, private health insurers, and clinicians.
- Mental Health Solution Digital mental health platform combining gamified computational psychiatry tasks (trust games, decision-making challenges, emotion-processing exercises) with generative AI-guided intake using LLMs. Applies reinforcement learning and Bayesian inference for personalised cognitive profiling and provides bridging care for patients awaiting formal mental health treatment. Delivered through subsidiary PsychoNext. Targeted at NHS mental health services, private health insurers, and individual patients.
Quantifiable outcome
- Reduces unnecessary GP appointments through AI-powered pre-triage
- +3 more outcomes
Companies that use DRNEXT LTD
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
DRNEXT LTD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature4 records
DRNEXT LTD partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DrNext.ir (Iran Operations)coreOriginal digital health platform in Iran serving 15M+ patients, 70M+ visits, and 15,000+ physicians. Provides proven infrastructure, data assets, and operational experience that underpins the UK expansion. Shares founder Dr. Saeid Taheri and core technology platform.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
DRNEXT LTD competitors and assessment
Company assessmentEmerging players
- Skin Analytics: UK-based AI dermatology platform using machine learning for skin cancer detection and NHS pathway integration — comparable to DrNext's AI Cancer Risk Detection in AI-driven oncology and NHS integration approach.
- Kheiron Medical: AI medical imaging company focused on cancer detection (notably breast cancer screening) — comparable to DrNext's AI Cancer Risk Detection in AI-driven oncology positioning, though Kheiron's modality is imaging rather than symptom-based.
- Doccla: UK virtual ward and remote patient monitoring platform working with NHS trusts — partially comparable to DrNext in NHS-focused digital health delivery and chronic/acute care pathway integration.
- C the Signs: UK AI platform for early cancer detection using symptom-based risk assessment integrated with NHS pathways — directly comparable to DrNext's AI Cancer Risk Detection in symptom-based cancer prediction and NHS 2WW integration.
- Limbic: UK AI mental health platform using machine learning to improve access to psychological therapies and integrate with NHS IAPT pathways — comparable to DrNext's Mental Health Solution in AI-driven mental health and NHS targeting.
Direct peers
- Babylon Health: UK-based digital health platform offering AI symptom triage and virtual GP consultations to NHS organisations and patients — directly comparable in product mix (AI triage + virtual GP), NHS target customer, and B2B/B2C hybrid model.
- Push Doctor: UK-based digital GP service providing video consultations to NHS patients and private users — closely comparable to DrNext's Virtual GP product in customer segment, delivery mechanism, and UK NHS focus.
- Ada Health: AI-powered symptom assessment platform serving consumers, health systems, and insurers globally — directly comparable to DrNext's AI Symptom Checker in core functionality, probabilistic reasoning approach, and enterprise health system partnerships.
- Kry (Livi): European digital GP platform providing video consultations and AI-assisted triage across the UK and Nordics — comparable to DrNext's Virtual GP and AI Symptom Checker offering and similar NHS/private-pay hybrid GTM.
Broad incumbents
- Teladoc Health: Global telehealth incumbent offering virtual care, AI triage, and chronic condition management across multiple geographies — a broad incumbent with overlapping virtual primary care and AI capabilities relevant to DrNext's product portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
DRNEXT LTD social profiles
Digital presenceDRNEXT LTD financial estimates
Financial estimateRevenue estimate
Valuation estimate
DRNEXT LTD leadership team
Management profileNumber of profiles
Profiles9 records
DRNEXT LTD subsidiaries and ownership
Company hierarchySubsidiaries1 record
DRNEXT LTD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DRNEXT LTD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DRNEXT LTD
What does DRNEXT LTD do?
DrNext provides an AI-powered digital health platform comprising four modular products: an AI Symptom Checker for intelligent triage trained on 50 million patient records; a Virtual GP platform offering same-day video consultations with integrated EHR and referral tools; an AI Cancer Risk Detection system using machine learning to predict high-risk patients without imaging; and a Mental Health Solution combining gamified computational psychiatry with LLM-guided intake. The platform is licensed to NHS organisations and private health insurers and is also accessible directly to individual patients.
Is DRNEXT LTD a public or private company?
DRNEXT LTD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DRNEXT LTD founded?
DRNEXT LTD was founded in 2021. It employs 1 to 10 people.
Where is DRNEXT LTD based?
DRNEXT LTD is headquartered in London, United Kingdom, in the Europe region.
How does DRNEXT LTD make money?
Three revenue lines are on record. NHS/Healthcare System Licensing is the primary driver. The others are private Health Insurer Licensing and direct-to-Patient Services.
Who are DRNEXT LTD's main competitors?
Emerging players on record are Skin Analytics, Kheiron Medical, Doccla, C the Signs and Limbic. Direct peers are Babylon Health, Push Doctor, Ada Health and Kry (Livi). Teladoc Health is listed as a broad incumbent.
Does DRNEXT LTD have an API?
No public API is recorded for DRNEXT LTD.
What industry is DRNEXT LTD in?
DRNEXT LTD's product category is Digital Health Platform. Its primary akta.pro industry code is HLALAJAM, Integrated Virtual-First Primary + Urgent Hybrid Platforms, with a secondary code of HLALAAAA, Primary Care & General Medicine Virtual Care. Its NAICS code is 621112 and its SIC code is 8000.